Is STIM Worth Buying in 2026?

Neuronetics, Inc. Common Stock

STOCK SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Updated 2026-08-16

Here’s whether Neuronetics, Inc. Common Stock (STIM) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+16.77% over 10 days); 3-month momentum positive (+157.8%); rising volume confirms the move (1.59x 30d avg). Concerns: RSI 79 — overbought, elevated pullback risk. Currently 14.9% off its 52-week high. Score: +5/7.

Ready to act on this? 📈 Trade on Webull

STIM is in a confirmed uptrend, trading above both its 50-day ($1.76) and 200-day ($1.65) moving averages. With an RSI of 79.0, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of -7.3% compares to +20.4% for SPY (trailed the market by 27.7%).

$10,000 invested 1 year ago → $9,270 today
vs. S&P 500 (SPY) — same period trailed market by 27.7%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($1.65)
Above 50-day MA ($1.76)
!RSI(14) neutral zone (30–70) — currently 79.0
Positive return (-7.3%)
!Within 10% of period high (−14.9%)
Period Range $3.30
$0.80 $3.88
RSI (14) 79.0
0 · OversoldOverbought · 100

Key Metrics

Price$3.30
Period Return-7.3%
Period High$3.88
Period Low$0.80
Drawdown−14.9%
MA-50$1.76
MA-200$1.65
RSI (14)79.0
Avg Volume (30d)3.1M
vs. SPYtrailed by 27.7%
Return Rank#765 of 1252

Trade STIM

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers